Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUSRE36634 E
Publication typeGrant
Application numberUS 08/711,685
Publication dateMar 28, 2000
Filing dateSep 5, 1996
Priority dateDec 12, 1991
Fee statusLapsed
Also published asUS5344418
Publication number08711685, 711685, US RE36634 E, US RE36634E, US-E-RE36634, USRE36634 E, USRE36634E
InventorsShahriar Ghaffari
Original AssigneeGhaffari; Shahriar
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Optical system for treatment of vascular lesions
US RE36634 E
Abstract
An improved optical system for treatment of disorders of the skin, especially vascular lesions, such as Port Wine Stains. The system irradiates the skin with radiation at a predetermined wavelength and cools the skin during a predetermined time interval in coordination with delivery of the radiation. The absorption of the radiation by the skin and the change in temperature of the skin is monitored by the system and the operation of the radiation delivery system is controlled to optimize treatment of the vascular lesion. The source of irradiation is an arc lamp and the cooling system delivers a cooling gas to a lens in contact with the skin. The cooling gas can be carbon dioxide, freon, or any other appropriate gas. The lens used has a high heat conductivity and may be formed of sapphire.
Images(11)
Previous page
Next page
Claims(13)
What is claimed is:
1. An optical system for treating vascular lesions, comprising:
irradiating means for irradiating skin with electromagnetic radiation;
monitoring means coupled to said irradiating means for monitoring absorption of said radiation by said skin;
controlling means coupled to said monitoring means and said irradiating means for controlling the operation of said irradiating means to deliver a predetermined dose of radiation to said skin; and
cooling means coupled to said irradiating means for cooling the surface of said skin, said cooling means comprising:
a lens having one side in contact with said skin, wherein said lens is comprised of a material that is transparent to visible light and has a high thermal conductivity; and
means for circulating a cooling .[.gas.]. .Iadd.medium .Iaddend.to contact with said lens on the side not in contact with said skin.
2. The system of claim 1, wherein said irradiating means comprises an arc lamp.
3. The system of claim 2, wherein said monitoring means comprises means for measuring the time of .[.absorption.]. .Iadd.delivery .Iaddend.of radiation.
4. The system of claim 2, wherein said monitoring means comprises means for measuring the reflection of radiation from the skin.
5. The system of claim 1, wherein said cooling .[.gas.]. .Iadd.medium .Iaddend.comprises freon.
6. The system of claim 1, wherein said cooling .[.gas.]. .Iadd.medium .Iaddend.comprises carbon dioxide.
7. The system of claim 1, wherein said lens material is sapphire.
8. The system of claim 1, wherein said lens material is diamond. .Iadd.
9. A method of treatment with light energy comprising the steps of:
providing a pulsed light output having a spectrum of frequencies continuous over at least one bandwidth from a non-laser, incoherent light source; and
directing said pulsed light output to skin, said pulsed light having controllable irradiation parameters to produce a controlled peak temperature at a variable controlled depth below a surface of said skin to selectively coagulate a target in said skin. .Iaddend..Iadd.10. A method of treating skin, comprising the steps of:
cooling a surface of skin to a predetermined temperature; and
irradiating said skin with electromagnetic radiation, at a predetermined time relative to initiation of said step of cooling said skin to produce a controlled peak temperature at a variable controlled depth. .Iaddend..Iadd.11. The method according to claim 10, said step of irradiating said skin with electromagnetic radiation further comprising the step of controlling a source of electromagnetic radiation to provide
pulses of electromagnetic radiation. .Iaddend..Iadd.12. An apparatus for treating skin, comprising:
pulsed cooling means operable to cool a surface of skin to a predetermined temperature; and
a source of electromagnetic radiation for irradiating said skin with electromagnetic radiation at a predetermined time relative to pulses of said pulsed cooling said skin to produce a controlled peak temperature at a variable controlled depth below a surface of said skin. .Iaddend..Iadd.13. The apparatus according to claim 12, said source of electromagnetic radiation being operable to provide pulses of
electromagnetic radiation. .Iaddend..Iadd.14. The apparatus of claim 12, wherein said predetermined time is subsequent to the cooling of said skin.
.Iaddend..Iadd.15. A method of treating skin, comprising the steps of:
heating a portion of skin;
cooling the surface of said skin; and
controlling said heating and cooling steps of establish a controlled temperature at said skin surface and a controlled peak temperature at a
variable controlled depth below said surface. .Iaddend..Iadd.16. The method according to claim 15, wherein said cooling step comprises contacting said skin with a cooled lens comprising a material with a high thermal conductivity. .Iaddend..Iadd.17. The method of claim 16, said lens comprising sapphire. .Iaddend.
Description
FIELD OF THE INVENTION

The present invention relates to an optical system for treatment of disorders of the skin, especially vascular lesions, such as Port Wine Stains.

BACKGROUND

PortWine Stains (PWS) are congenital disorders of the skin in which vascular malformations produce red-colored isolated lesions occurring most commonly on the face, trunk and neck. The lesion is basically an area of localized enlarged and ectatic blood vessels in the upper dermis. PWS tends to progress from a pale pink and flat lesions in childhood to nodular and dark red-purple lesions in adulthood. Its unpleasant cosmetic appearance causes psychological stress and makes the patient seek medical help. The goal of PWS treatment is to restore the normal color of the skin by selectively destroying the enlarged blood vessels while keeping the rest of the cutaneous structures intact.

The prior art method of choice for treatment of PWS is photocoagulation of the enlarged blood vessels. Ideally, absorption of the laser light by hemoglobin increases the temperature of the abnormal blood vessels until coagulation of blood and vessel walls takes place. Wavelengths for treatment of PWS are usually selected because of their high absorption by hemoglobin. The argon laser with lines at 488 and 514.4 nm has been selected for treatment of PWS because of its high absorption in blood. Recently better coupling has been achieved by matching a pulse dye laser to the 577 nm peak of oxygenated hemoglobin. However, coagulation of the enlarged vessels has been demonstrated at other wavelengths such as 1.06 and 10.6 μm.

Ideally, laser treatment should selectively destroy dermal blood vessels up to a depth of approximately 0.6 mm without causing damage to the epidermis, and especially to the epidermal-dermal layer since damage to this layer disturbs the healing process and may lead to scarring. Epidermal melanin, however, is also an important chromophore with strong absorption in the ultraviolet that decreases through the visible spectrum. Melanin, therefore, has been a potential barrier for the incident laser light causing hearing of the epidermis and reducing the amount of light which reaches the underlying blood vessels.

One of the most recent lasers for the treatment of PortWine Stain is the pulsed dye laser tuned to 577 nm, which is at one of the high absorption peaks of hemoglobin. At 577 nm absorption by epidermal melanin and scattering by the dermis is lower than at the 540 nm peak or at argon wavelengths. The rate of heat generation is higher in the blood vessels than in the epidermis. Although pulse durations of 1 μs or less cause microvascular hemorrhage, 360 μs pulses seem to be very effective in causing selective vascular damage without excessive damage to the epidermis or non-vascular dermal structure. Although investigators report no scarring or any apparent epidermal damage after treatment of PWS lesions with 360 μs pulse 577 nm dye laser, at a dose of 6.5 to 10 J/cm2, only an overall lightening of 42% has been obtained in the PWS lesions after the initial treatment, and retreatment sessions improved the overall lightening to 68%. Higher energy doses per treatment may produce unwanted epidermal or dermal damage.

A pulsed dye laser system is expensive for an average Dermatologist with a limited purchasing power. However, in the treatment of vascular lesions the coherence of the laser beam is not a critical consideration as long as a light source with proper powers at the right wavelengths can be focused onto the skin with spot sizes in the range of 3-5 mm in diameter (similar to the spot sizes reported in such applications).

The tunable dye laser based systems have been very effective in exploring the mechanisms of the PWS treatments. At the present, the purchasing cost of such laser based systems is approximately $150,000 and the annual maintenance is estimated to be $25,000 per laser system. Consequently, most Dermatologists can not justify the high cost of purchasing a laser based systems for this application. Another cost consideration is the patients who may not be able to afford the high costs of such treatments. Therefore, there is a need for a low-cost system to achieve the same treatment for a much lower cost than the present treatment cost. Such a system is provided by the present invention, described in greater detail below.

SUMMARY OF THE INVENTION

The present invention provides an improved optical system for treatment of disorders of the skin, especially vascular lesions, such as PortWine Stains. In the preferred embodiment of the present invention the system comprises means for irradiating the skin with radiation at a predetermined wavelength. The system also comprises means for cooling the skin during a predetermined time interval in coordination with delivery of the radiation. The absorption of the radiation by the skin and the change in temperature of the skin is monitored by the system and the operation of the radiation delivery system is controlled to optimize treatment of the vascular lesion. In the preferred embodiment of the invention, the source of irradiation is an arc lamp. The means for cooling comprises a system for delivering a cooling gas to a lens in contact with the skin. The cooling gas can be carbon dioxide, freon, or any other appropriate gas. The lens used in the preferred embodiment is formed of sapphire.

BRIEF DESCRIPTION OF THE DRAWINGS

Further advantages and a more complete understanding of the invention can be obtained by referring to the following detailed description of specific embodiments when taken in conjunction with the accompanying drawings in which:

FIG. 1 is an illustration of a blood vessel in relation to the dermis and epidermis.

FIG. 2 is a graphical illustration of the volumetric heat generated in skin as a function of depth for 500 nm light.

FIG. 3 is a graphical illustration of the absorption of light produce by an arc lamp by blood.

FIG. 4 is a graphical illustration of the spectral emission of a Mercury-Xenon arc lamp.

FIG. 5 is a graphical illustration the rate of heat generation as a function of wavelength of irradiation for blood, dermis and epidermis.

FIG. 6 is a graphical illustration of skin absorption and scattering characteristics.

FIGS. 7a-7b is an illustration of the preferred embodiment of the system for delivering radiation to the skin in accordance with the present invention.

FIGS. 8a-8d is an illustration of alternate embodiments of the system for delivering radiation to the skin in accordance with the present invention.

FIG. 9 is an illustration of a computer based control system for controlling the rate of irradiation of the treatment area.

FIG. 10 is a graphical illustration of the effects of cooling on skin.

FIG. 11 is a graphical illustration of volumetric heat generated in skin as a function of depth for irradiation at 577 nm.

FIG. 12 is the maximum dermal depth as a function of wavelength where the heat production at the top of the blood vessel is larger than at the epidermal-dermal junction using Monte Carlo and Kubelka-Munk theories.

FIG. 13 is a graphical illustration of skin temperature as a function of depth for cooling at various rates.

FIGS. 14a-14b are flow charts of the control and processing steps implemented in the system of the present invention.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Optically, the skin can be represented by two layers: a thin absorbing layer (epidermis) and predominantly scattering layer (dermis), as shown in FIG. 1. The enlarged blood vessels in PWS are located mainly at a distance of 0.3 to 0.6 mm from the epidermal-dermal junction. Blood vessels are typically modeled as either a thin absorbing layer or as individual cylinders or spheres. The goal of PWS treatment is to restore the normal color of the skin by selectively destroying the enlarged blood vessels while keeping the rest of the cutaneous structures intact.

The rate of heat generation S[W/cm3 ] in the tissue due to absorption of radiation is:

S(z)=μa(z) φ(z)

where μa is the local absorption coefficient and φ(z) is the fluence rate. The rate of heat generation at 500 nm is shown in FIG. 2.

The wavelength spectrum of lasers presently used for PWS treatment vary from 488 nm up to 590 nm with the optimum treatment at 585 nm. FIG. 3, which is the blood absorption characteristic as a function of wavelength, reveals that the absorption of blood (HbO and Hb) is not sharp in a small neighborhood of the selected laser wavelengths. The advantage of using a dye laser at 585 nm appears to be the higher penetration depths with minimal epidermal heating and scarring. It has been suggested that an argon laser would perform better if the heat could be removed from the surface.

The light source employed in the present invention is a "Mercury Vapor Arc lamp" with a wavelength characteristic shown in FIG. 4. However, other light sources may be utilized, such as a xenon arc lamp. Arc lamp power ratings up to 10,000 watts are commercially available. However, an Arc lamp with a power rating of 2500 watts would produce sufficient light intensity for vascular lesion treatments. An important characteristic of the lamp is that it produces two narrow linewidths of light about the peaks of 546 and 579 nm, which coincide with blood absorption peaks at 540 and 577 nm. The lamp spectral distribution with respect to the blood absorption spectrum is shown in FIG. 3. The Full Width Half Maximum (FWHM) of the lamp peak at 579 is 10 nm and at 546 is 6 nm.

If the entire band of wavelengths from 530 to 560 nm is used (using the Arc lamp) then the epidermal temperature may exceed the temperature of blood vessels deeper than 0.28 mm. Consequently, the present invention includes a temperature compensation and monitoring system, discussed in greater detail below, to reduce the epidermal and dermal temperatures such that the overall system produces, in the epidermis and dermis, temperatures at least as low as the dye lasers at 577 or 585 nm.

EFFECT OF NARROW-BAND ARC LAMP ON SKIN

FIG. 3 is the blood absorption coefficient in the range of 450-600 nm with the corresponding characteristic of the Arc lamp spectrum. The resultant rate of heat generation in blood, epidermis and dermis are shown in FIG. 5.

The difference in the rate of heat generation in the epidermis and dermis for Arc lamp irradiation will result in higher temperatures as compared to the dye laser at 577 and 585 nm at equal irradiance. Since the epidermal heat generation is approximately 3.5 times that of dermis, the dermis will always be at lower temperatures than epidermis. As a result, the temperature of epidermis must be lowered during the Arc lamp irradiation to remove the excess heat generated. The worst case heating of the epidermis is the case of using only 500 nm irradiation. The absorption coefficients at 500 nm, using FIG. 6, are: Ab =140 and Ae =38, Ad =12 cm-1. Therefore, the expected temperature in epidermis is 1.72 times more than the case for the dye lasers at 577 and 585 nm (1.36 times higher irradiance @ 1.26 times higher absorption).

The epidermal temperature increase using a dye laser is assumed to be approximately 20 C. In order to achieve an equivalent blood vessel coagulation at 0.6 mm depths using 500 nm, the epidermis temperature must be brought down approximately 15 C. below the normal skin temperature, before irradiation. This is the worst case situation in using the Arc lamp. The system of the present invention is capable of cooling the skin to temperatures as low as 5 C., which is more than the cooling capability needed for this treatment.

The system show in FIGS. 7a-7b and the alternate embodiment shown in FIGS. 8a-8d is used to deliver light energy to skin while controlling the amount of radiation delivered. Referring to FIG. 7a, the delivery device 10 comprises a housing 12 containing optic components and a cable 14 comprising a fiber bundle 16 and gas channels 18a and 18b for transporting gas to and from the interior of the housing 12. A fiber terminator 20 directs light carried by the fiber bundle 16 toward a primary lens 22. The light passed by the primary lens 22 is reflected by the dichroic mirror 24 toward a secondary mirror 26 which passes the light to a sapphire lens 28 contained in the tip of a conical housing 30. The conical housing includes channels 32a and 32b for transporting cooling gas to the sapphire lens 28. The sapphire lens 28 is placed in contact with the surface of the skin to be treated. The sapphire lens will be cooled by CO2 gas (or freon) flowing around the fiber tip and the lens 28 via the channels 18a, 18b and 32a, 32b, as shown in FIG. 7a. The CO2 may be replaced with freon if desired. A viewing window 34 in the top of the housing can be used to observe the interaction of the radiation with the skin to monitor the progress of the treatment.

Referring now to FIGS. 8a-8d, an alternate embodiment of the invention is shown. Elements that are identical to the elements appearing in FIGS. 7a-7b are designated with the same reference numbers for simplicity. As shown in FIG. 8a, delivery device 210 comprises a housing 12 comprising a fiber bundle 16 as well as various optic components. The fiber bundle 16 provides light energy or electromagnetic radiation to fiber terminator 20 which in turn directs the light carried by the fiber bundle 16 to a sapphire lens 28. The sapphire lens 28 produces a collimated beam of light which is then applied to the skin as shown. The delivery device 210 further includes gas flow ports 144a, 144b, 146a and 146b as shown. The gas ports 144a and 144b receive a cooling gas which enters into the housing and then comes in contact with the sapphire lens 28 as shown. After making this contact, the gas then exits from the gas ports 146a and 146b as shown.

The embodiment of delivery device 212 shown in FIG. 8b is essentially similar except that the light carried by the fiber bundle 16 is passed through a first lens 152 and then to a second lens 154 which focuses the beam through a sapphire window 156 as shown onto the skin.

FIG. 8d illustrates the gas flow ports on the outside of the housing 12. Gas ports 144a and 144b are shaded to reflect that gas flow is into the device, and gas ports 146a and 146b are unshaded to reflect that gas exits these ports. As shown in FIG. 8d, the housing 12 may contain any number, i.e. more than four, gas flow ports.

FIG. 8c illustrates the gas flow pattern of the device 210. As shown, the gas flow ports 144a and 144b receive gas from outside of the housing and direct this gas toward the sapphire lens 28. The gas comes in contact with the sapphire lens 28 and then passes outside one of the gas flow exit ports, for example, gas flow port 146a.

FIG. 9 shows a system wherein the components discussed above are used in connection with a computer to monitor and control the operation of the optical delivery system. The light produced by an arc lamp 50 is focused by a reflector 52 and directed toward a "cold" mirror 54. The cold mirror is a dichroic mirror which passes 90% of the infrared radiation produced by the arc lamp 50 and thus reflecting only approximately 10% of the infrared light. A heat sink 56 absorbs the infrared fight passed by the cold mirror 54. The light which is reflected by the cold mirror passes through a shutter 58 and a dichroic filter 60 to be received by a fiber optic terminator 62 secured to a mirror 64. It is not necessary for the filter 60 to be capable of absorbing large amounts of infrared radiation, since the infrared has been effectively removed by passing through the cold mirror 54. The light received by the terminator 62 is transmitted via fiber bundle 66 to the delivery system 10. Light reflected by the skin is transmitted via cable 68 to a reflection monitoring system comprising a filter 70 and a detector 72, which produces an output signal corresponding to the intensity and wavelength of the reflected light. The computer 74 which is used as the feedback controller, directly controls the shutter 58 between the light source and the fiber tip. Output irradiance of the system may be controlled by using built-in tables stored in the computer memory for different irradiation parameters. The specific surface temperature and irradiation parameters may also be preset by the operator through the computer 74.

FIGS. 14a and 14b illustrate the processing steps to control the system of the present invention. In step 100 the power to the lamp is initialized and in step 102 the temperature of the lamp is monitored. In step 104, a determination is made of whether the lamp is at the maximum temperature. If the lamp is at the maximum temperature, then the system is shut down in step 106. However, if the lamp is not at the maximum temperature, then a determination is made in step 108 of whether the lamp is at operating temperature. If the lamp is not at operating temperature, then the temperature is adjusted in step 110 and the system returns to step 102. However, if the lamp is at the operating temperature, then the system proceeds to step 112 where a determination is made of whether the foot pedal switch is activated. If the foot pedal is not activated, the system returns to step 108. However, if the foot pedal is activated, the cooling system is activated in step 114 and the power supply is pulsed in step 116. In step 118, the dose of radiation delivered to the skin is measured using two methods--time of delivery and reflection of radiation by the skin. In step 120 a decision is made of whether sufficient radiation has been delivered to the skin. If sufficient radiation has not been delivered, then the system continues to deliver radiation in step 122. However, if sufficient radiation has been delivered, then the pulse is turned off in step 124 and the shutter is closed in step 124. In step 128, a decision is made of whether the procedure is complete. If the procedure is not complete, the probe is moved to a new location and the system proceeds to step 108. However, if the procedure is complete, the system is powered down in step 132.

SURFACE COOLING DURING LIGHT IRRADIATION

Prior investigators have reported that cooling the skin with ice packs prior to treatment of PortWine Stains with argon laser radiation decreased the incidence of scarring. Other investigators, using Neodymium-YAG laser, also reported reduced damage to the epidermis by skin-cooling techniques using direct spraying of freon during laser irradiation. Other reports further suggest that varying skin temperature has an effect on the dose required to produce purpura in human skin with a pulse tunable dye laser.

The surface cooling over a long period of time (i.e. hundreds of seconds) causes blood vessel reactions. The small blood vessels (i.e. less than 100-150 microns) will be shut down if the cooling of the skin is continued for several minutes. After prolonged cooling of the skin at temperatures below 15 C., the blood vessels enlarge. Previous data indicate a sudden change in blood flow as the blood vessel temperature is decreased below approximately 15 C.

The advantage of controlled epidermal surface cooling during irradiation is the lower temperature of the epidermis. The main consideration in cooling the skin surface is the cooling rate which must be controlled for a near ideal treatment. The surface cooling effect for the case of a simple thick medium (with tissue parameters, i.e. Absorption=23 cm-1, Scattering=10 cm-1) irradiated with 2 W, 2 mm Argon laser beam for 250 millisecond, has been simulated on a computer and the results are shown in FIG. 10. The curves for several cases from no-cooling up to a large convective cooling are shown in FIG. 10. The curves due to surface cooling clearly indicate a much lower temperature at the surface than that of the non-cooling curve. Surface cooling may cause the maximum temperature to move away from the surface.

FIGS. 2 and 11 are the expected rate of heat generation as a function of depth in skin for wavelengths of 500 nm and 577 nm. These curves are based on one-dimensional diffusion theory and should represent the rate of heat generation at the center of a 3-5 mm spot. Considering both cases of FIG. 2 and FIG. 11, it may be concluded that the maximum depth to which the blood vessels are destroyed, at any wavelength, is the depth that the temperature of the blood vessels is equal to the temperature of epidermis. For example, the maximum depth that the dye laser may destroy the blood vessels at 577 nm case (FIG. 11 ) is approximately 0.6 mm whereas at the same depth the 500 nm wavelength does not produce as much temperature due to its lower blood absorption coefficient.

FIG. 12 is the maximum dermal depth as a function of wavelength where the heat production at the top of the blood vessel is larger than at the epidermal-dermal junction using Monte Carlo and Kubelka-Munk theories. Different wavelengths from 525 to 585 nm may produce blood vessel coagulation in depths of interest; however, the wavelengths in the vicinity of 546 and 577 nm may be more suitable. Irradiation containing the band of wavelengths around the 546 nm peak produces a higher epidermal temperature increase than an equal irradiance containing the band of wavelengths around 577 nm peak (for the case of the Arc lamp). However, surface cooling will reduce the epidermal temperatures such that the epidermal temperature increase due to the wavelengths around the 546 peak becomes closer to that of the peak around 577 nm. The two peaks of interest in the light source and their interaction is explained in the next section.

SYSTEM FOR CONTROL OF SKIN TEMPERATURE

The temperature cooling system provided by the present invention is a pulsed cooling system with capability of dropping the skin surface temperature to 5 C. in about 100 milliseconds. The computed temperature response of the skin for a fixed surface temperature of 5 C., and the onset of light irradiation after 100 ms is shown in FIG. 13. Blood vessels at a depth of 100 microns are cooled to 20 C. at the onset of light irradiation.

As the surface temperature of the skin is rapidly cooled to approximately 5 C., temperatures in the epidermis and upper dermis will be lower than the normal skin temperature. The epidermal temperatures at the beginning of irradiation are lower than temperatures when cooling is omitted. At the end of an irradiation pulse of 10-50 milliseconds, blood vessels are coagulated when temperatures reach 65 to 75 C. With surface cooling corresponding peak temperatures at the epidermal-dermal junction are expected to be in the range of 40 to 50 C. Since rapid cooling of the skin creates lower blood vessel temperatures in the anterior vessels than the posterior vessels; the temperature of the vessels during light irradiation will be more uniform with depth than the present laser treatment.

Due to its thermal properties, sapphire or diamond are particularly suitable material for this application. They are transparent to visible light, allowing the laser beam to pass through and at the same time they possess high thermal conductivities (25 W/m K and higher) or higher, allowing rapid transfer of heat which produces a lower temperature that advance to the front of the lens (and to the skin surface if the sapphire lens is touching the skin) while irradiation is being performed. Prior to the application, the skin surface must be exposed to saline or transparent ointments with high heat conductivity for better heat coupling efficiencies. The freon or CO2 flow is controlled by a computer monitoring feedback system to keep the skin temperature at or above 5 C.

The system provided by the present invention offers numerous advantages over the prior art systems. The estimated manufacturing cost of the proposed system is much lower than a laser dye system. The lower manufacturing cost may reduce the treatment cost dramatically.

Another advantage of the proposed system is the ability to control the treatment by changing the rate of cooling, irradiation time and the spectrum of the irradiation light. The maximum temperatures for the dermis and blood vessels can be adjusted by changing the treatment protocol.

The superficial blood vessels may be "shut down" by the rapid cooling; as a result, the cooling system may initially shut down the superficial blood vessels so that the light would coagulate the deeper vessels. The proposed delivery system allows an increase in the total light energy delivered, so more abnormal blood vessels can be destroyed while preserving the epidermis and the epidermal-dermal junction. In other words, more lightening of the PWS lesion may be obtained with less risk of scarring.

The system will be easy to use and can be moved freely on the skin keeping the skin at the same relative distance from the lenses.

Presently used lasers are not power efficient. The efficiency of some lasers used in this application may be as low as 0.01%. The Arc lamp is a much more efficient system. Total light generation capability of the Arc lamp is in the order of 40-60%. In this application only 9% of the light is used for the treatment which makes this system more efficient than the dye lasers. A reasonably sized portable system may be feasible if there is a need for such device. Finally, due to the large area cooling system, the pain may be reduced.

While the foregoing discussion of the invention contains many specificities, these should not be construed as limiting the scope of the invention, but rather as merely providing illustrations of exemplary embodiments of the invention. Many other variations and modifications of the invention will be apparent to those of skill in the art without departing from the spirit and the scope of the invention as defined by the appended claims and their equivalents.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3693623 *Dec 25, 1970Sep 26, 1972Gregory System IncPhotocoagulation means and method for depilation
US3821510 *Feb 22, 1973Jun 28, 1974Muncheryan HHand held laser instrumentation device
US4316467 *Jun 23, 1980Feb 23, 1982Lorenzo P. MaunControl for laser hemangioma treatment system
US4539987 *Jun 4, 1984Sep 10, 1985Nath GuentherApparatus for coagulation by heat radiation
US4733660 *Dec 10, 1986Mar 29, 1988Medical Laser Research And Development CorporationLaser system for providing target specific energy deposition and damage
US5057104 *May 30, 1989Oct 15, 1991Cyrus ChessMethod and apparatus for treating cutaneous vascular lesions
US5071417 *Jun 15, 1990Dec 10, 1991Rare Earth Medical Lasers, Inc.Laser fusion of biological materials
US5112328 *Aug 7, 1990May 12, 1992Refractive Laser Research & Development Program, Ltd.Method and apparatus for laser surgery
US5282797 *May 28, 1991Feb 1, 1994Cyrus ChessMethod for treating cutaneous vascular lesions
US5405368 *Oct 20, 1992Apr 11, 1995Esc Inc.Method and apparatus for therapeutic electromagnetic treatment
US5626631 *Feb 3, 1995May 6, 1997Esc Medical Systems Ltd.Method and apparatus for therapeutic electromagnetic treatment
Non-Patent Citations
Reference
1Anvari et al, "Selective cooling . . . procedures", Phys. Med. Biol., vol 40, pp. 241-252. 1995.
2 *Anvari et al, Selective cooling . . . procedures , Phys. Med. Biol., vol 40, pp. 241 252. 1995.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6273885 *Aug 16, 1998Aug 14, 2001Cooltouch CorporationHandheld photoepilation device and method
US6436094 *Mar 16, 2000Aug 20, 2002Laserscope, Inc.Electromagnetic and laser treatment and cooling device
US6508813Mar 12, 1999Jan 21, 2003Palomar Medical Technologies, Inc.System for electromagnetic radiation dermatology and head for use therewith
US6511475Aug 9, 2000Jan 28, 2003The General Hospital CorporationHeads for dermatology treatment
US6517532Dec 28, 1999Feb 11, 2003Palomar Medical Technologies, Inc.Light energy delivery head
US6605080Mar 26, 1999Aug 12, 2003The General Hospital CorporationMethod and apparatus for the selective targeting of lipid-rich tissues
US6653618Apr 30, 2001Nov 25, 2003Palomar Medical Technologies, Inc.Contact detecting method and apparatus for an optical radiation handpiece
US6663620Jan 18, 2002Dec 16, 2003Palomar Medical Technologies, Inc.Light energy delivery head
US6682524 *Aug 11, 1999Jan 27, 2004Asclepion Laser Technologies GmbhDermatological hand piece
US6723090Jul 2, 2002Apr 20, 2004Palomar Medical Technologies, Inc.Fiber laser device for medical/cosmetic procedures
US6976985Apr 17, 2003Dec 20, 2005Palomar Medical Technologies, Inc.Light energy delivery head
US6991644Dec 5, 2003Jan 31, 2006Cutera, Inc.Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US6997923Dec 27, 2001Feb 14, 2006Palomar Medical Technologies, Inc.Method and apparatus for EMR treatment
US7060061Aug 12, 2003Jun 13, 2006Palomar Medical Technologies, Inc.Method and apparatus for the selective targeting of lipid-rich tissues
US7077840 *Oct 21, 2002Jul 18, 2006Palomar Medical Technologies, Inc.Heads for dermatology treatment
US7083610 *Jun 7, 2000Aug 1, 2006LaserscopeDevice for irradiating tissue
US7090670Dec 31, 2003Aug 15, 2006Reliant Technologies, Inc.Multi-spot laser surgical apparatus and method
US7108689Sep 19, 2002Sep 19, 2006Lumenis LtdMethod and apparatus for electromagnetic treatment of the skin, including hair depilation
US7118563 *Feb 19, 2004Oct 10, 2006Spectragenics, Inc.Self-contained, diode-laser-based dermatologic treatment apparatus
US7144248Jun 16, 2003Dec 5, 2006Irwin Dean SDevice for oral UV photo-therapy
US7147654Jan 24, 2003Dec 12, 2006LaserscopeTreatment Site Cooling System of Skin Disorders
US7184184Dec 31, 2003Feb 27, 2007Reliant Technologies, Inc.High speed, high efficiency optical pattern generator using rotating optical elements
US7196831Aug 9, 2004Mar 27, 2007Reliant Technologies, Inc.Two-dimensional optical scan system using a counter-rotating disk scanner
US7250045Feb 19, 2004Jul 31, 2007Spectragenics, Inc.Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
US7276059 *Mar 12, 2004Oct 2, 2007PhotomedexTreatment of skin disorders with UV light and cooling
US7282060Dec 21, 2004Oct 16, 2007Reliant Technologies, Inc.Method and apparatus for monitoring and controlling laser-induced tissue treatment
US7372606Jun 20, 2005May 13, 2008Reliant Technologies, Inc.Optical pattern generator using a single rotating component
US7411711Feb 26, 2007Aug 12, 2008Reliant Technologies, Inc.High speed, high efficiency optical pattern generator using rotating optical elements
US7413567Feb 25, 2004Aug 19, 2008Spectragenics, Inc.Optical sensor and method for identifying the presence of skin
US7413572Jun 14, 2004Aug 19, 2008Reliant Technologies, Inc.Adaptive control of optical pulses for laser medicine
US7452355 *Jul 25, 2001Nov 18, 2008Vladimir Valentinovich KhomchenkoMethod of laser coagulation of blood vessels
US7452356Feb 19, 2004Nov 18, 2008Tria Beauty, Inc.Eye-safe dermatologic treatment apparatus
US7480086Sep 4, 2007Jan 20, 2009Reliant Technologies, Inc.High speed, high efficiency optical pattern generator using rotating optical elements
US7636186Oct 31, 2007Dec 22, 2009Reliant Technologies, Inc.High speed, high efficiency optical pattern generator using rotating optical elements
US7691099Apr 6, 2010Ntk Enterprises, Inc.Deuterated ocular solutions for LTK and other surgical eye procedures
US7758621Jul 20, 2010Palomar Medical Technologies, Inc.Method and apparatus for therapeutic EMR treatment on the skin
US7763016Jul 27, 2010Palomar Medical Technologies, Inc.Light energy delivery head
US7886749Feb 15, 2011PhotomedexTreatment of skin disorders with UV light and cooling
US7891361May 8, 2006Feb 22, 2011PhotomedexMethods for UV photo-therapy
US7935107May 3, 2011Palomar Medical Technologies, Inc.Heads for dermatology treatment
US7942915Nov 13, 2006May 17, 2011Palomar Medical Technologies, Inc.Phototreatment device for use with coolants
US7942916Dec 1, 2006May 17, 2011Palomar Medical Technologies, Inc.Phototreatment device for use with coolants and topical substances
US7981111Feb 25, 2004Jul 19, 2011Tria Beauty, Inc.Method and apparatus for the treatment of benign pigmented lesions
US8002768Aug 23, 2011Palomar Medical Technologies, Inc.Light energy delivery head
US8109924Feb 7, 2012Palomar Medical Technologies, Inc.Heads for dermatology treatment
US8182473Nov 22, 2006May 22, 2012Palomar Medical TechnologiesCooling system for a photocosmetic device
US8268332Apr 1, 2005Sep 18, 2012The General Hospital CorporationMethod for dermatological treatment using chromophores
US8291913Oct 23, 2012Reliant Technologies, Inc.Adaptive control of optical pulses for laser medicine
US8328794Sep 22, 2008Dec 11, 2012Palomar Medical Technologies, Inc.System for electromagnetic radiation dermatology and head for use therewith
US8328796Jul 11, 2011Dec 11, 2012Palomar Medical Technologies, Inc.Light energy delivery head
US8346347Jan 1, 2013Palomar Medical Technologies, Inc.Skin optical characterization device
US8454669Feb 18, 2011Jun 4, 2013PhotomedexDevice for UV photo-therapy
US8486056Mar 3, 2010Jul 16, 2013PhotomedexTreatment of skin disorders with UV light
US8551104Oct 10, 2006Oct 8, 2013Tria Beauty, Inc.Self-contained, diode-laser-based dermatologic treatment apparatus
US8603081Aug 14, 2008Dec 10, 2013Ntk Enterprises, Inc.System and method for defining and controlling LTK and other surgical eye procedures to produce little or no stromal collagen shrinkage
US8685017Jun 6, 2007Apr 1, 2014Thermage, Inc.Method and kit for treatment of tissue
US8709003Aug 8, 2008Apr 29, 2014Tria Beauty, Inc.Capacitive sensing method and device for detecting skin
US8777935Aug 18, 2008Jul 15, 2014Tria Beauty, Inc.Optical sensor and method for identifying the presence of skin
US8915948Feb 15, 2008Dec 23, 2014Palomar Medical Technologies, LlcMethod and apparatus for photothermal treatment of tissue at depth
US9028536Aug 3, 2009May 12, 2015Cynosure, Inc.Picosecond laser apparatus and methods for its operation and use
US9113900Jan 31, 2012Aug 25, 2015Covidien AgMethod and system for controlling output of RF medical generator
US9113934May 16, 2011Aug 25, 2015Covidien LpOptical energy-based methods and apparatus for tissue sealing
US9162078Sep 14, 2012Oct 20, 2015Mela Sciences, Inc.Treatment of skin disorders with UV light
US9168089Jan 31, 2012Oct 27, 2015Covidien AgMethod and system for controlling output of RF medical generator
US9351792Jul 19, 2007May 31, 2016The General Hospital CorporationMethod and apparatus for dermatological treatment and fractional skin resurfacing
US20030055414 *Oct 21, 2002Mar 20, 2003Altshuler Gregory B.Heads for dermatology treatment
US20030065314 *Sep 17, 2002Apr 3, 2003Palomar Medical Technologies, Inc.System for electromagnetic radiation dermatology and head for use therewith
US20030069567 *Sep 19, 2002Apr 10, 2003Shimon EckhouseMethod and apparatus for electromagnetic treatment of the skin, including hair depilation
US20030109860 *Dec 12, 2001Jun 12, 2003Michael BlackMultiple laser treatment
US20030195494 *Apr 17, 2003Oct 16, 2003Altshuler Gregory B.Light energy delivery head
US20030199859 *May 21, 2003Oct 23, 2003Altshuler Gregory B.Method and apparatus for the selective targeting of lipid-rich tissues
US20030212393 *Mar 31, 2003Nov 13, 2003Knowlton Edward W.Handpiece with RF electrode and non-volatile memory
US20030233138 *Jun 12, 2002Dec 18, 2003Altus Medical, Inc.Concentration of divergent light from light emitting diodes into therapeutic light energy
US20040000316 *Mar 31, 2003Jan 1, 2004Knowlton Edward W.Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US20040002704 *Mar 31, 2003Jan 1, 2004Knowlton Edward W.Treatment apparatus with electromagnetic energy delivery device and non-volatile memory
US20040030332 *Mar 31, 2003Feb 12, 2004Knowlton Edward W.Handpiece with electrode and non-volatile memory
US20040034319 *Mar 12, 2003Feb 19, 2004Palomar Medical Technologies, Inc.Method and apparatus for hair growth management
US20040034346 *Mar 25, 2003Feb 19, 2004Stern Roger A.RF device with thermo-electric cooler
US20040073079 *Jun 19, 2003Apr 15, 2004Palomar Medical Technologies, Inc.Method and apparatus for treatment of cutaneous and subcutaneous conditions
US20040082940 *Oct 23, 2002Apr 29, 2004Michael BlackDermatological apparatus and method
US20040116984 *Dec 5, 2003Jun 17, 2004Greg SpoonerMethod and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US20040147984 *Nov 4, 2003Jul 29, 2004Palomar Medical Technologies, Inc.Methods and apparatus for delivering low power optical treatments
US20040162549 *Nov 12, 2003Aug 19, 2004Palomar Medical Technologies, Inc.Method and apparatus for performing optical dermatology
US20040167500 *Feb 19, 2004Aug 26, 2004Weckwerth Mark V.Self-contained, diode-laser-based dermatologic treatment apparatus and method
US20040260367 *Apr 6, 2004Dec 23, 2004Luis De TaboadaDevice and method for providing phototherapy to the heart
US20050015124 *Mar 12, 2004Jan 20, 2005Irwin Dean S.Treatment of skin disorders with UV light and cooling
US20050049582 *Jul 9, 2004Mar 3, 2005Debenedictis Leonard C.Method and apparatus for fractional photo therapy of skin
US20050107851 *Sep 10, 2004May 19, 2005Taboada Luis D.Device and method for providing phototherapy to the brain
US20050137658 *Dec 17, 2003Jun 23, 2005Hennings David R.Treatment of superficial pigmented and vascular lesions of the skin
US20050141068 *Dec 31, 2003Jun 30, 2005Debenedictis Leonard C.High speed, high efficiency optical pattern generator using rotating optical elements
US20050143719 *Dec 31, 2003Jun 30, 2005Sink Robert K.Multi-spot laser surgical apparatus and method
US20050177208 *Jun 16, 2003Aug 11, 2005Irwin Dean S.Device for oral UV photo-therapy
US20050203491 *Jul 25, 2001Sep 15, 2005Khomchenko Vladimir V.Method of laser coagulation of blood vessels
US20050215988 *Mar 25, 2005Sep 29, 2005Palomar Medical Technologies, Inc.Method and apparatus for medical treatment utilizing long duration electromagnetic radiation
US20050259306 *Aug 9, 2004Nov 24, 2005Broome Barry GTwo-dimensional optical scan system using a counter-rotating disk scanner
US20050278002 *Jun 14, 2004Dec 15, 2005David EimerlAdaptive control of optical pulses for laser medicine
US20060004306 *Apr 1, 2005Jan 5, 2006Palomar Medical Technologies, Inc.Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20060009750 *Jun 27, 2005Jan 12, 2006Palomar Medical Technologies, Inc.Apparatus and method for treatment using a patterned mask
US20060020309 *Apr 1, 2005Jan 26, 2006Palomar Medical Technologies, Inc.Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20060058712 *Apr 1, 2005Mar 16, 2006Palomar Medical Technologies, Inc.Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20060089687 *Nov 14, 2005Apr 27, 2006Greg SpoonerSystem for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US20060111760 *Dec 28, 2005May 25, 2006Lajos KemenyPhototherapeutical method and system for the treatment of inflammatory and hyperproliferative disorders of the nasal mucosa
US20060155266 *Mar 25, 2004Jul 13, 2006Dieter MansteinMethod and apparatus for dermatological treatment and fractional skin resurfacing
US20060161143 *Dec 12, 2005Jul 20, 2006Palomar Medical Technologies, Inc.Light energy delivery head
US20060197247 *Apr 18, 2006Sep 7, 2006Moldflow Pty LtdAutomated Molding Technology For Thermoplastic Injection Molding
US20060206103 *Feb 17, 2006Sep 14, 2006Palomar Medical Technologies, Inc.Dermatological treatment device
US20060253176 *Feb 17, 2006Nov 9, 2006Palomar Medical Technologies, Inc.Dermatological treatment device with deflector optic
US20060271028 *Feb 17, 2006Nov 30, 2006Palomar Medical Technologies, Inc.Dermatological treatment device
US20060276778 *Aug 15, 2006Dec 7, 2006Reliant Technologies, Inc.Multi-Spot Laser Surgical Apparatus and Method
US20060276862 *May 8, 2006Dec 7, 2006Irwin Dean STreatment of skin disorders with UV light and cooling
US20060287646 *May 19, 2006Dec 21, 2006Palomar Medical Technologies, Inc.Method and apparatus for therapeutic EMR treatment on the skin
US20070010811 *Sep 12, 2006Jan 11, 2007Thermage, Inc.energy delivery device for treating tissue
US20070032847 *Oct 10, 2006Feb 8, 2007Spectragenics, Inc.Self-contained, diode-laser-based dermatologic treatment apparatus
US20070038206 *May 1, 2006Feb 15, 2007Palomar Medical Technologies, Inc.Photocosmetic device
US20070067006 *Nov 13, 2006Mar 22, 2007Palomar Medical Technologies, Inc.Phototreatment device for use with coolants
US20070129711 *Nov 22, 2006Jun 7, 2007Altshuler Gregory BCooling system for a photocosmetic device
US20070194717 *Feb 17, 2006Aug 23, 2007Palomar Medical Technologies, Inc.Lamp for use in a tissue treatment device
US20070213696 *May 1, 2006Sep 13, 2007Palomar Medical Technologies, Inc.Photocosmetic device
US20070219604 *Oct 27, 2006Sep 20, 2007Palomar Medical Technologies, Inc.Treatment of tissue with radiant energy
US20070219605 *Oct 27, 2006Sep 20, 2007Palomar Medical Technologies, Inc.Treatment of tissue volume with radiant energy
US20070239142 *May 1, 2006Oct 11, 2007Palomar Medical Technologies, Inc.Photocosmetic device
US20070255274 *Jun 6, 2007Nov 1, 2007Thermage, Inc.Method and kit for treatment of tissue
US20070255355 *Apr 6, 2007Nov 1, 2007Palomar Medical Technologies, Inc.Apparatus and method for skin treatment with compression and decompression
US20070282402 *Aug 20, 2007Dec 6, 2007PhotomedexTreatment of skin disorders with uv light and cooling
US20080033413 *Sep 24, 2007Feb 7, 2008Palomar Medical Technologies, Inc.Flashlamp drive circuit
US20080043306 *Sep 4, 2007Feb 21, 2008Debenedictis Leonard CHigh Speed, High Efficiency Optical Pattern Generator Using Rotating Optical Elements
US20080068694 *Oct 31, 2007Mar 20, 2008Reliant Technologies, Inc.High speed, high efficiency optical pattern generator using rotating optical elements
US20080139901 *Feb 14, 2008Jun 12, 2008Palomar Medical Technologies, Inc.Cooling System For A Photocosmetic Device
US20080161745 *Sep 7, 2007Jul 3, 2008Oliver StumppBleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system
US20080161782 *Oct 26, 2007Jul 3, 2008Reliant Technologies, Inc.Micropore delivery of active substances
US20080183162 *Dec 28, 2007Jul 31, 2008Palomar Medical Technologies, Inc.Methods And Devices For Fractional Ablation Of Tissue
US20080186591 *Feb 1, 2007Aug 7, 2008Palomar Medical Technologies, Inc.Dermatological device having a zoom lens system
US20080288032 *May 8, 2006Nov 20, 2008PhotomedexDevice for UV photo-therapy
US20080294153 *Feb 15, 2008Nov 27, 2008Palomar Medical Technologies, Inc.Cooling System For A Photocosmetic Device
US20090043294 *Aug 8, 2008Feb 12, 2009Spectragenics, Inc.Capacitive Sensing Method and Device for Detecting Skin
US20090054879 *Aug 14, 2008Feb 26, 2009Ntk Enterprises, Inc.System and method for defining and controlling ltk and other surgical eye procedures to produce little or no stromal collagen shrinkage
US20090125006 *Aug 18, 2008May 14, 2009Spectragenics, Inc.Optical Sensor and Method for Identifying the Presence of Skin
US20090137994 *Aug 18, 2008May 28, 2009Rellant Technologies, Inc,Adaptive control of optical pulses for laser medicine
US20090204109 *Nov 14, 2008Aug 13, 2009Tria Beauty, Inc.Eye-Safe Dermatologic Treatment Apparatus and Method
US20090270848 *Oct 29, 2009Tria Beauty, Inc.Optical Sensor and Method for Identifying the Presence of Skin and the Pigmentation of Skin
US20100069898 *Mar 18, 2010Tria Beauty, Inc.Acne Treatment Method, System and Device
US20100204686 *Aug 12, 2010Palomar Medical Technologies, Inc.Light treatments for acne and other disorders of follicles
US20110004280 *Jan 6, 2011PhotomedexTreatment of skin disorders with uv light
US20110196457 *Aug 11, 2011PhotomedexDevice for uv photo-therapy
USRE42594Aug 2, 2011Reliant Technologies, Inc.Tissue cooling rod for laser surgery
USRE43881Jun 21, 2011Dec 25, 2012Reliant Technologies, Inc.Tissue cooling rod for laser surgery
Classifications
U.S. Classification606/9, 606/13, 607/89
International ClassificationA61B17/00, A61B18/22, A61F7/00, A61B18/20, A61B18/00, A61B18/18
Cooperative ClassificationA61B18/203, A61B2018/00452, A61B2017/00057, A61B2018/1807, A61B2018/2272, A61B2018/00029, A61B2018/2266, A61F2007/0065, A61B2017/00756
European ClassificationA61B18/20H
Legal Events
DateCodeEventDescription
Sep 1, 2006LAPSLapse for failure to pay maintenance fees